{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T14:31:15Z","timestamp":1780497075675,"version":"3.54.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2016,6,16]],"date-time":"2016-06-16T00:00:00Z","timestamp":1466035200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["RG\/13\/16\/30528"],"award-info":[{"award-number":["RG\/13\/16\/30528"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1007\/s00125-016-4011-7","type":"journal-article","created":{"date-parts":[[2016,6,16]],"date-time":"2016-06-16T05:58:02Z","timestamp":1466056682000},"page":"1904-1912","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Copeptin and the risk of incident stroke, CHD and cardiovascular mortality in older men with and without diabetes: The British Regional Heart Study"],"prefix":"10.1007","volume":"59","author":[{"given":"S. Goya","family":"Wannamethee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Welsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy","family":"Lennon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olia","family":"Papacosta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter H.","family":"Whincup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naveed","family":"Sattar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,6,16]]},"reference":[{"key":"4011_CR1","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.2337\/dc12-1513","volume":"36","author":"KS Taylor","year":"2013","unstructured":"Taylor KS, Heneghan CJ, Farmer AJ et al (2013) All-cause and cardiovascular mortality in middle-aged people with type 2 diabetes compared with people without diabetes in a large U.K. primary care database. Diabetes Care 36:2366\u20132371","journal-title":"Diabetes Care"},{"key":"4011_CR2","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1093\/eurheartj\/eht108","volume":"34","author":"L Ryd\u00e9n","year":"2013","unstructured":"Ryd\u00e9n L, Grant PJ, Anker SD et al (2013) ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD). Eur Heart J 34:3035\u20133087","journal-title":"Eur Heart J"},{"key":"4011_CR3","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S1474-4422(12)70005-4","volume":"11","author":"MJ Luitse","year":"2012","unstructured":"Luitse MJ, Biessels GJ, Rutten GE et al (2012) Diabetes, hyperglycaemia and acute ischaemic stroke. Lancet Neurol 11:261\u2013271","journal-title":"Lancet Neurol"},{"key":"4011_CR4","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/jcbfm.2014.24","volume":"34","author":"G Faraco","year":"2014","unstructured":"Faraco G, Wijasa TS, Park L et al (2014) Water deprivation induces neurovascular and cognitive dysfunction through vasopressin-induced oxidative stress. J Cereb Blood Flow Metab 34:852\u2013860","journal-title":"J Cereb Blood Flow Metab"},{"key":"4011_CR5","doi-asserted-by":"crossref","first-page":"3973","DOI":"10.1210\/jc.2007-0232","volume":"92","author":"G Szinnai","year":"2007","unstructured":"Szinnai G, Morgenthaler NG, Berneis K et al (2007) Changes in plasma copeptin, the c-terminal portion of arginine vasopressin during water deprivation and excess in healthy subjects. J Clin Endocrinol Metab 92:3973\u20133978","journal-title":"J Clin Endocrinol Metab"},{"key":"4011_CR6","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/01.CCM.0000251127.45385.CD","volume":"35","author":"LK Barrett","year":"2007","unstructured":"Barrett LK, Singer M, Clapp LH (2007) Vasopressin mechanisms of action on the vasculature in health and in septic shock. Crit Care Med 35:33\u201340","journal-title":"Crit Care Med"},{"key":"4011_CR7","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1124\/mol.65.3.623","volume":"65","author":"S Oshikawa","year":"2004","unstructured":"Oshikawa S, Tanoue A, Koshimizu TA et al (2004) Vasopressin stimulates insulin release from islet cells through V1b receptors: a combined pharmacological\/knockout approach. Mol Pharmacol 65:623\u2013629","journal-title":"Mol Pharmacol"},{"key":"4011_CR8","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/j.1365-2265.1985.tb00145.x","volume":"22","author":"BA Spruce","year":"1985","unstructured":"Spruce BA, McCulloch AJ, Burd J et al (1985) The effect of vasopressin infusion on glucose metabolism in man. Clin Endocrinol (Oxf) 22:463\u2013468","journal-title":"Clin Endocrinol (Oxf)"},{"key":"4011_CR9","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.ejphar.2008.11.043","volume":"602","author":"M Hiroyama","year":"2009","unstructured":"Hiroyama M, Fujiwara Y, Nakamura K et al (2009) Altered lipid metabolism in vasopressin V1B receptor-deficient mice. Eur J Pharmacol 602:455\u2013461","journal-title":"Eur J Pharmacol"},{"key":"4011_CR10","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000045879","volume":"87","author":"L Bankir","year":"2001","unstructured":"Bankir L, Bardoux P, Ahloulay M (2001) Vasopressin and diabetes mellitus. Nephron 87:8\u201318","journal-title":"Nephron"},{"key":"4011_CR11","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1373\/clinchem.2005.060038","volume":"52","author":"NG Morgenthaler","year":"2006","unstructured":"Morgenthaler NG, Struck J, Alonso C et al (2006) Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin. Clin Chem 52:112\u2013119","journal-title":"Clin Chem"},{"key":"4011_CR12","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/ijo.2012.88","volume":"37","author":"S Enh\u00f6rning","year":"2013","unstructured":"Enh\u00f6rning S, Bankir L, Bouby N et al (2013) Copeptin, a marker of vasopressin, in abdominal obesity, diabetes and microalbuminuria: the prospective Malm\u00f6 Diet and Cancer Study cardiovascular cohort. Int J Obes (Lond) 37:598\u2013603","journal-title":"Int J Obes (Lond)"},{"key":"4011_CR13","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.1210\/JC.2015-2362","volume":"100","author":"SG Wannamethee","year":"2015","unstructured":"Wannamethee SG, Welsh P, Papacosta O et al (2015) Copeptin, insulin resistance and risk of incident diabetes in older men. J Clin Endocrinol Metab 100:3332\u20133339","journal-title":"J Clin Endocrinol Metab"},{"key":"4011_CR14","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.2337\/dc08-2168","volume":"32","author":"C Maier","year":"2009","unstructured":"Maier C, Clodi M, Neuhold S et al (2009) Endothelial markers may link kidney function to cardiovascular events in type 2 diabetes. Diabetes Care 32:1890\u20131895","journal-title":"Diabetes Care"},{"key":"4011_CR15","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1681\/ASN.2010070691","volume":"22","author":"W Fenske","year":"2011","unstructured":"Fenske W, Wanner C, Allolio B et al (2011) Copeptin levels associate with cardiovascular events in patients with ESRD and type 2 diabetes mellitus. J Am Soc Nephrol 22:782\u2013790","journal-title":"J Am Soc Nephrol"},{"key":"4011_CR16","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.2337\/dc10-0088","volume":"33","author":"LG Mellbin","year":"2010","unstructured":"Mellbin LG, Ryd\u00e9n L, Brismar K et al (2010) Copeptin, IGFBP-1, and cardiovascular prognosis in patients with type 2 diabetes and acute myocardial infarction: a report from the DIGAMI 2 trial. Diabetes Care 33:1604\u20131606","journal-title":"Diabetes Care"},{"key":"4011_CR17","doi-asserted-by":"crossref","first-page":"3201","DOI":"10.2337\/dc12-2165","volume":"36","author":"IJ Riphagen","year":"2013","unstructured":"Riphagen IJ, Boertien WE, Alkhalaf A et al (2013) Copeptin, a surrogate marker for arginine vasopressin, is associated with cardiovascular and all-cause mortality in patients with type 2 diabetes (ZODIAC-31). Diabetes Care 36:3201\u20133207","journal-title":"Diabetes Care"},{"key":"4011_CR18","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.ahj.2014.11.020","volume":"169","author":"S Enh\u00f6rning","year":"2015","unstructured":"Enh\u00f6rning S, Hedblad B, Nilsson PM et al (2015) Copeptin is an independent predictor of diabetic heart disease and death. Am Heart J 169:549\u2013556","journal-title":"Am Heart J"},{"key":"4011_CR19","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1007\/s00415-009-5143-1","volume":"256","author":"D Sander","year":"2009","unstructured":"Sander D, Kearney MT (2009) Reducing the risk of stroke in type 2 diabetes: pathophysiological and therapeutic perspectives. J Neurol 256:1603\u20131609","journal-title":"J Neurol"},{"key":"4011_CR20","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1136\/bmj.283.6285.179","volume":"283","author":"AG Shaper","year":"1981","unstructured":"Shaper AG, Pocock SJ, Walker M et al (1981) British Regional Heart Study: cardiovascular risk factors in middle-aged men in 24 towns. BMJ 283:179\u2013186","journal-title":"BMJ"},{"key":"4011_CR21","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1161\/hc1502.107117","volume":"105","author":"SG Wannamethee","year":"2002","unstructured":"Wannamethee SG, Lowe GD, Whincup PH et al (2002) Physical activity and hemostatic and inflammatory variables in elderly men. Circulation 105:1785\u20131790","journal-title":"Circulation"},{"key":"4011_CR22","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1258\/000456302320314511","volume":"39","author":"J Emberson","year":"2002","unstructured":"Emberson J, Whincup PH, Walker M et al (2002) Biochemical measures in a population based study: the effect of fasting duration and time of day. Ann Clin Biochem 39:493\u2013501","journal-title":"Ann Clin Biochem"},{"key":"4011_CR23","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1177\/000456326900600108","volume":"6","author":"P Trinder","year":"1969","unstructured":"Trinder P (1969) Determination of blood glucose in blood using glucose oxidase with an alternative oxygen acceptor. Ann Clin Biochem 6:24\u201327","journal-title":"Ann Clin Biochem"},{"key":"4011_CR24","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1093\/clinchem\/39.4.578","volume":"39","author":"L Andersen","year":"1993","unstructured":"Andersen L, Dinesen B, Jorgensen PN et al (1993) Enzyme immunoassay for intact human insulin in serum or plasma. Clin Chem 39:578\u2013582","journal-title":"Clin Chem"},{"key":"4011_CR25","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews DR, Hosker JP, Rudenski AS et al (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412\u2013419","journal-title":"Diabetologia"},{"key":"4011_CR26","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","volume":"130","author":"AS Levey","year":"1999","unstructured":"Levey AS, Bosch JP, Lewis JB et al (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130:461\u2013470","journal-title":"Ann Intern Med"},{"key":"4011_CR27","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.2337\/dc09-9033","volume":"32","author":"International Expert Committee","year":"2009","unstructured":"International Expert Committee (2009) International Expert Committee report on the role of the A1c assay in the diagnosis of diabetes. Diabetes Care 32:1327\u20131334","journal-title":"Diabetes Care"},{"key":"4011_CR28","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/eurjhf\/hft124","volume":"16","author":"SG Wannamethee","year":"2014","unstructured":"Wannamethee SG, Welsh P, Whincup P et al (2014) N-terminal pro brain natriuretic peptide but not copeptin improves prediction of heart failure over other routine clinical risk parameters in older men with and without cardiovascular disease: population-based study. Eur J Heart Fail 16:25\u201332","journal-title":"Eur J Heart Fail"},{"key":"4011_CR29","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1093\/ije\/dyv141","volume":"44","author":"LT Lennon","year":"2015","unstructured":"Lennon LT, Ramsay SE, Papacosta O et al (2015) Cohort profile update: The British Regional Heart Study 1978\u20132014: 35 years follow-up of cardiovascular disease and ageing. Int J Epidemiol 44:826\u2013826g","journal-title":"Int J Epidemiol"},{"key":"4011_CR30","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1093\/pubmed\/22.4.479","volume":"22","author":"M Walker","year":"2000","unstructured":"Walker M, Shaper AG, Lennon L et al (2000) Twenty year follow-up of a cohort based in general practices in 24 British towns. J Public Health Med 22:479\u2013485","journal-title":"J Public Health Med"},{"key":"4011_CR31","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1093\/oxfordjournals.aje.a009653","volume":"148","author":"M Walker","year":"1998","unstructured":"Walker M, Whincup PH, Shaper AG et al (1998) Validation of patient recall of doctor diagnosed heart attack and stroke: a postal questionnaire and record review comparison. Am J Epidemiol 148:355\u2013361","journal-title":"Am J Epidemiol"},{"key":"4011_CR32","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jacc.2008.03.050","volume":"52","author":"S Neuhold","year":"2008","unstructured":"Neuhold S, Huelsmann M, Strunk G et al (2008) Comparison of copeptin, B-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic\u00a0heart failure: prediction of death at different stages of the disease. J Am Coll Cardiol 52:266\u2013272","journal-title":"J Am Coll Cardiol"},{"key":"4011_CR33","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ijcard.2011.12.105","volume":"162","author":"S Haehling von","year":"2012","unstructured":"von Haehling S, Papassotiriou J, Morgenthaler NG et al (2012) Copeptin as a prognostic factor for major adverse cardiovascular events in patients with coronary artery disease. Int J Cardiol 162:27\u201332","journal-title":"Int J Cardiol"},{"key":"4011_CR34","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1136\/heartjnl-2011-301269","volume":"98","author":"M Potocki","year":"2012","unstructured":"Potocki M, Reichlin T, Thalmann S et al (2012) Diagnostic and prognostic impact of copeptin and high-sensitivity cardiac troponin T in patients with pre-existing coronary artery disease and suspected acute myocardial infarction. Heart 98:558\u2013565","journal-title":"Heart"},{"key":"4011_CR35","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1038\/sj.jcbfm.9600097","volume":"25","author":"A Vakili","year":"2005","unstructured":"Vakili A, Kataoka H, Plesnila N (2005) Role of arginine vasopressin V1 and V2 receptors for brain damage after transient focal cerebral ischaemia. J Cereb Blood Flow Metab 25:1012\u20131019","journal-title":"J Cereb Blood Flow Metab"},{"key":"4011_CR36","doi-asserted-by":"crossref","first-page":"11665","DOI":"10.1038\/srep11665","volume":"5","author":"KS Choi","year":"2015","unstructured":"Choi KS, Kim HJ, Chun HJ et al (2015) Prognostic role of copeptin after stroke: a systematic review and meta-analysis of observational studies. Sci Rep 5:11665","journal-title":"Sci Rep"},{"key":"4011_CR37","doi-asserted-by":"crossref","first-page":"c4249","DOI":"10.1136\/bmj.c4249","volume":"341","author":"M Lee","year":"2010","unstructured":"Lee M, Saver JL, Chang KH et al (2010) Low glomerular filtration rate and risk of stroke: meta-analysis. BMJ 341:c4249","journal-title":"BMJ"},{"key":"4011_CR38","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1007\/s00125-013-2922-0","volume":"56","author":"WE Boertien","year":"2013","unstructured":"Boertien WE, Riphagen IJ, Drion I et al (2013) Copeptin, a surrogate marker for arginine vasopressin, is associated with declining glomerular filtration in patients with diabetes mellitus (ZODIAC-33). Diabetologia 56:1680\u20131688","journal-title":"Diabetologia"},{"key":"4011_CR39","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/ki.2009.397","volume":"77","author":"E Meijer","year":"2010","unstructured":"Meijer E, Bakker SJ, Halbesma N et al (2010) Copeptin, a surrogate marker of vasopressin, is associated with microalbuminuria in a large population cohort. Kidney Int 77:29\u201336","journal-title":"Kidney Int"},{"key":"4011_CR40","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.2337\/dc08-1079","volume":"31","author":"X Yang","year":"2008","unstructured":"Yang X, Ko GT, So WY et al (2008) Additive interaction of hyperglycemia and albuminuria on risk of ischemic stroke in type 2 diabetes: Hong Kong Diabetes Registry. Diabetes Care 31:2294\u20132300","journal-title":"Diabetes Care"},{"key":"4011_CR41","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1161\/STROKEAHA.110.581215","volume":"41","author":"M Lee","year":"2010","unstructured":"Lee M, Saver JL, Chang KH et al (2010) Impact of microalbuminuria on incident stroke: a meta-analysis. Stroke 41:2625\u20132631","journal-title":"Stroke"},{"issue":"22","key":"4011_CR42","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","volume":"373","author":"B Zinman","year":"2015","unstructured":"Zinman B, Wanner C, Lachin JM et al (2015) Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N Engl J Med 373(22):2117\u20132128","journal-title":"N Engl J Med"},{"key":"4011_CR43","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1681\/ASN.2004121079","volume":"16","author":"L Bankir","year":"2005","unstructured":"Bankir L, Fernandes S, Bardoux P et al (2005) Vasopressin-V2 receptor stimulation reduces sodium excretion in healthy humans. J Am Soc Nephrol 16:1920\u20131928","journal-title":"J Am Soc Nephrol"},{"key":"4011_CR44","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1136\/bmj.298.6666.75","volume":"298","author":"PAG Sandercock","year":"1989","unstructured":"Sandercock PAG, Warlow CP, Jones LN et al (1989) Predisposing factors for cerebral infarction: the Oxfordshire Community Stroke Project. BMJ 298:75\u201380","journal-title":"BMJ"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-016-4011-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00125-016-4011-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-016-4011-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,22]],"date-time":"2020-09-22T09:58:36Z","timestamp":1600768716000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00125-016-4011-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,16]]},"references-count":44,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["4011"],"URL":"https:\/\/doi.org\/10.1007\/s00125-016-4011-7","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,16]]}}}